ATE423200T1 - Neues plexin-polypeptid, dieses codierende dna und verwendung davon - Google Patents
Neues plexin-polypeptid, dieses codierende dna und verwendung davonInfo
- Publication number
- ATE423200T1 ATE423200T1 AT04793105T AT04793105T ATE423200T1 AT E423200 T1 ATE423200 T1 AT E423200T1 AT 04793105 T AT04793105 T AT 04793105T AT 04793105 T AT04793105 T AT 04793105T AT E423200 T1 ATE423200 T1 AT E423200T1
- Authority
- AT
- Austria
- Prior art keywords
- polypeptide
- seq
- dna
- amino acid
- acid sequence
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 8
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 8
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 8
- 102000002022 plexin Human genes 0.000 title 1
- 108050009312 plexin Proteins 0.000 title 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 4
- 210000000056 organ Anatomy 0.000 abstract 3
- 230000033115 angiogenesis Effects 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 1
- 238000007792 addition Methods 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 238000012217 deletion Methods 0.000 abstract 1
- 230000037430 deletion Effects 0.000 abstract 1
- 230000018109 developmental process Effects 0.000 abstract 1
- 230000004069 differentiation Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000004064 dysfunction Effects 0.000 abstract 1
- 238000004321 preservation Methods 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000008929 regeneration Effects 0.000 abstract 1
- 238000011069 regeneration method Methods 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003371040 | 2003-10-30 | ||
| JP2004229871 | 2004-08-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE423200T1 true ATE423200T1 (de) | 2009-03-15 |
Family
ID=34680588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04793105T ATE423200T1 (de) | 2003-10-30 | 2004-10-28 | Neues plexin-polypeptid, dieses codierende dna und verwendung davon |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7482322B2 (de) |
| EP (1) | EP1679372B1 (de) |
| JP (1) | JP4751202B2 (de) |
| AT (1) | ATE423200T1 (de) |
| DE (1) | DE602004019556D1 (de) |
| WO (1) | WO2005056791A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0613425A2 (pt) | 2005-07-21 | 2012-10-30 | Stichting Katholieke Univ | plexina d1, uso de moléculas, moléculas de ligação de plexina d1, composição diagnóstica, composição terapêutica, e, método para identificar moléculas que são capazes de se ligar a plexina dl |
| EP2385121A1 (de) | 2010-05-06 | 2011-11-09 | Netris Pharma | Antagonisten der Sema3E/PlexinD1-Interaktion als Antikrebswirkstoff |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63203626A (ja) * | 1987-02-19 | 1988-08-23 | Ajinomoto Co Inc | 免疫抑制剤 |
| WO2001057188A2 (en) * | 2000-02-03 | 2001-08-09 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
| WO2001014420A2 (en) | 1999-08-25 | 2001-03-01 | University Of Torino | Novel members of the plexin family and uses thereof |
| JP4711520B2 (ja) * | 2000-03-21 | 2011-06-29 | 日本ケミカルリサーチ株式会社 | 生理活性ペプチド含有粉末 |
| US7892730B2 (en) * | 2000-12-22 | 2011-02-22 | Sagres Discovery, Inc. | Compositions and methods for cancer |
| WO2002081745A2 (en) | 2001-04-05 | 2002-10-17 | Proskelia Pharmaceuticals | Genes involved in osteogenesis, and methods of use |
| CA2469941A1 (en) * | 2001-12-10 | 2003-07-03 | Nuvelo, Inc. | Novel nucleic acids and polypeptides |
| EP1534739A4 (de) * | 2002-01-18 | 2006-05-31 | Bristol Myers Squibb Co | Identifizierung von polynukleotiden und polypeptid zur vorhersage der aktivität von verbindungen, die mit protein-tyrosinkinasen und/oder protein-tyrosinkinasewegen wechselwirken |
| AU2003210266A1 (en) * | 2002-02-14 | 2003-09-04 | Bioinvent International Ab | Treatment, diagnosis and imaging of disease |
| WO2003087768A2 (en) * | 2002-04-12 | 2003-10-23 | Mitokor | Targets for therapeutic intervention identified in the mitochondrial proteome |
| EP2322203A3 (de) * | 2002-10-29 | 2011-07-27 | Genentech, Inc. | Gestaltungen und methoden für die behandlung von Immune verwandte Krankheiten |
| EP2364716A3 (de) * | 2002-11-08 | 2012-01-11 | Genentech, Inc. | Zusammensetzungen und Verfahren zur Behandlung von Erkrankungen im Zusammenhang mit natürlichen Killerzellen |
| AU2003292231A1 (en) * | 2002-12-12 | 2004-06-30 | Novartis Ag | Methods for diagnosing and treating schizophrenia |
| WO2004082704A1 (ja) * | 2003-03-19 | 2004-09-30 | Dnavec Research Inc. | 骨破壊を伴う炎症性疾患の治療方法 |
-
2004
- 2004-10-28 JP JP2005516065A patent/JP4751202B2/ja not_active Expired - Fee Related
- 2004-10-28 EP EP04793105A patent/EP1679372B1/de not_active Expired - Lifetime
- 2004-10-28 WO PCT/JP2004/015997 patent/WO2005056791A1/ja not_active Ceased
- 2004-10-28 AT AT04793105T patent/ATE423200T1/de not_active IP Right Cessation
- 2004-10-28 DE DE602004019556T patent/DE602004019556D1/de not_active Expired - Lifetime
- 2004-10-28 US US10/573,262 patent/US7482322B2/en not_active Expired - Fee Related
-
2008
- 2008-12-22 US US12/318,086 patent/US7816132B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20070212365A1 (en) | 2007-09-13 |
| US20090215170A1 (en) | 2009-08-27 |
| US7816132B2 (en) | 2010-10-19 |
| WO2005056791A1 (ja) | 2005-06-23 |
| US7482322B2 (en) | 2009-01-27 |
| EP1679372B1 (de) | 2009-02-18 |
| EP1679372A4 (de) | 2006-11-08 |
| DE602004019556D1 (de) | 2009-04-02 |
| EP1679372A1 (de) | 2006-07-12 |
| JPWO2005056791A1 (ja) | 2007-12-06 |
| JP4751202B2 (ja) | 2011-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE430197T1 (de) | Fibroblasten wachstumsfaktor-ähnliche polypeptide | |
| UA48105C2 (uk) | ФРАГМЕНТ ДНК, ЯКИЙ КОДУЄ БІЛОК РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), РЕКОМБІНАНТНА МОЛЕКУЛА ДНК (ВАРІАНТИ), КЛІТИНА-ХАЗЯЇН (ВАРІАНТИ), СПОСІБ ОДЕРЖАННЯ БІЛКУ РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), БІЛОК РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ (ВАРІАНТИ), АНТИТІЛО АБО ФРАГМЕНТ АНТИТІЛА (ВАРІАНТИ), МОЛЕКУЛА КДНК (ВАРІАНТИ) | |
| DK1294876T3 (da) | EV-VEGF-nukleinsyrer og -polypeptider samt fremgangsmåder til deres benyttelse | |
| ATE540973T1 (de) | Zusammensetzungen und verfahren zur verwendung von mgd-cdf zur krankheitsbehandlung | |
| ATE182901T1 (de) | Für androgen-rezeptor-protein kodierende dna | |
| KR960704934A (ko) | 항혈전활성을 갖는 펩티드 및 이의 제조방법(Peptide having antithrombotic activity and process for producing the same) | |
| ATE380867T1 (de) | Lactoferrinrezeptorgen von moraxella | |
| ATE320484T1 (de) | Histone-deacetylase-8 proteine, nukleinsäuren und methoden zur verwendung | |
| DE60235985D1 (de) | Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk) | |
| WO2006042719A3 (de) | Polypeptid mit phytaseaktivität und dieses codierende nucleotidsequenz | |
| ATE423200T1 (de) | Neues plexin-polypeptid, dieses codierende dna und verwendung davon | |
| EP2354793A3 (de) | Nukleinsäuren und Proteine von Insekten OR83B-Duftrezeptorgenen und Verwendungen davon | |
| NO874704L (no) | Minaktivin fremstilt ved rekombinant dna-teknikk. | |
| MXPA05009954A (es) | Familia de proteinas secretadas. | |
| WO2003031566A3 (en) | Keratinocyte derived interferon | |
| ATE411338T1 (de) | Nukleinsäuremolekül, umfassend eine für ein hämocyanin kodierende nukleinsäuresequenz und mindestens eine intronsequenz | |
| DK1241179T3 (da) | Humant protein med in vitro antiproliferativ aktivitet. | |
| ATE415422T1 (de) | Menschliches gas-6 (growth arrest-specific gene 6) protein und dafür kodierende nukleinsäuren | |
| EP1568775A4 (de) | Krebs-assoziiertes gen | |
| ATE476194T1 (de) | Ein mitglied der menschlichen proteinkinasefamilie, und verwendungen dafür | |
| WO2003074675A3 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof | |
| RU2008130819A (ru) | Способ продукции рекомбинантной стафилокиназы при регулировании уровня кислорода | |
| ATE380864T1 (de) | Menschliches prostasin-ähnliches protein und dafür kodierende nukleinsäure | |
| WO2000063370A3 (en) | Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes | |
| ATE405590T1 (de) | Menschliches hcar-ähnliches protein und dafür kodierende nukleinsäure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |